Application analysis of oral hypolipidemic drugs in inpatient pharmacy of a hospital from 2019 to 2021
Objective To analyze the application situation and development trend of oral hypolipidemic drugs in Zhongshan Hospital,Fudan University(Xiamen Branch)(hereinafter referred to as"our hospital")from 2019 to 2021,evaluate the rationality of drug use,and provide reference for clinical rational drug use.Methods The usage data of hypolipidemic drugs in inpatient pharmacy of our hospital from 2019 to 2021 were selected from the hospital information management system(HIS),and the names,specifications,annual total amount of discharged drugs and annual total sales amount of such drugs were obtained.The adult defined daily dose(DDD),frequency of drug daily dose(DDDS)and drug daily cost(DDC)recommended by the World Health Organization(WHO)were statistically analyzed,and the synchronization of drug use was compared by ranking ratio(B/A).Results The average annual growth rate of drug consumption of oral hypolipidemic drugs in inpatient of our hospital from 2019 to 2021 was 8.19％,and the sales volume was relatively stable,showing an upward trend year by year.In them,the use of Statins was dominant,with the highest sales amount for three consecutive years,accounting for the largest proportion,followed by Bette class.In the DDDS ranking,Atorvastatin calcium tablets ranked first for three consecutive years,Fenofibrate capsules increased year by year,and ranked second for three consecutive years,while DDDS of other hypolipidemic drugs was relatively stable and fluctuated slightly.The DDC value of Simvastatin tablets was the highest,while the DDC value of Fenofibrate capsules was lower in three years.From 2019 to 2021,the B/A values of the vast majority of hypolipidemic drugs were close to 1,with a relatively good synchronization rate.Conclusion The use of oral hypolipidemic drugs for inpatients in our hospital from 2019 to 2021 is reasonable,and the selection is in line with the specifications.The types of drugs are relatively stable,and the use of drugs meets the requirements of the specification.
Hypolipidemic drugsFrequency of drug daily doseDrug use analysisAmount of drug consumptionAtorvastatin calcium tablets
国家科技期刊平台
NSTL
万方数据
